Harbourvest Partners’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-248,317
Closed -$2.59M 58
2023
Q3
$2.59M Hold
248,317
0.88% 16
2023
Q2
$1.36M Hold
248,317
0.38% 33
2023
Q1
$2.98M Hold
248,317
1% 16
2022
Q4
$2.04M Buy
248,317
+73,171
+42% +$1.9M 0.68% 20
2022
Q3
$7.49M Hold
175,146
2.45% 9
2022
Q2
$8.89M Hold
175,146
2.92% 8
2022
Q1
$11.3M Buy
175,146
+62,827
+56% +$3.14M 2.3% 9
2021
Q4
$5.87M Hold
112,319
0.75% 15
2021
Q3
$8.37M Hold
112,319
0.79% 15
2021
Q2
$11.3M Hold
112,319
1.08% 10
2021
Q1
$13.4M Hold
112,319
1.79% 10
2020
Q4
$14.6M Hold
112,319
5.69% 5
2020
Q3
$13M Hold
112,319
4.8% 4
2020
Q2
$15.5M Buy
112,319
+63,158
+128% +$7.73M 6.69% 2
2020
Q1
$4.2M Hold
49,161
2.03% 9
2019
Q4
$4.93M Hold
49,161
2.03% 8
2019
Q3
$6.96M Hold
49,161
2.89% 7
2019
Q2
$11.4M Buy
+49,161
New +$15.6M 4.19% 6

Other funds holding AXLA

Harbourvest Partners's AXLA Position: Q4 2023 in Review

Harbourvest Partners sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 248,317 shares — an estimated $2.59M sold.

Harbourvest Partners first reported a position in AXLA in Q2 2019 and held it in 18 quarters. The position peaked at $15.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.

  • Harbourvest Partners reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Harbourvest Partners sold 248,317 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $2.59M.
  • Harbourvest Partners first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Harbourvest Partners's Axcella Health Inc. Common Stock position peaked at $15.5M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.

Based on Harbourvest Partners's 13F filing for Q4 2023, filed 14 Feb 2024.